| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Products Manufactured in US | 24.2 | 26.5 | | | | | | |
| Products Manufactured in Europe | 11.3 | 9.2 | | | | | | |
| Products Manufactured in Asia | 3.9 | 2.3 | | | | | | |
| United States (Corpus Christi) | | | | 31.9 | 30.1 | 33.4 | | |
| Other | | 0.4 | | 14.8 | 15.9 | | | |
| Total revenues | 39.0 | 38.5 | 37.1 | 46.7 | 46.0 | 0.1 | 41.0 | 31.0 |
| Revenue growth [+] | 1.3% | 3.8% | -20.7% | 1.5% | 81133.1% | -99.9% | 32.3% | 28.2% |
| Products Manufactured in US | -9.0% | | | | | | | |
| Products Manufactured in Europe | 22.4% | | | | | | | |
| Products Manufactured in Asia | 68.9% | | | | | | | |
| United States (Corpus Christi) | | | | 5.8% | -9.7% | | | |
| Cost of goods sold | 35.4 | 33.4 | 35.2 | 40.1 | 42.6 | 0.0 | 31.7 | 24.3 |
| Gross profit | 3.6 | 5.1 | 1.9 | 6.6 | 3.5 | 0.0 | 9.3 | 6.8 |
| Gross margin | 9.1% | 13.2% | 5.1% | 14.2% | 7.5% | 21.1% | 22.7% | 21.8% |
| Selling, general and administrative | 4.7 | 4.2 | 4.5 | 4.8 | 4.7 | | 4.6 | 3.7 |
| Research and development | 0.2 | 0.2 | 0.2 | 0.2 | 0.7 | | 0.3 | 0.3 |
| Other operating expenses | | | | | | 0.0 | | |
| Adjusted EBITDA | 1.6 | 3.5 | 0.2 | 5.1 | 1.3 | 0.0 | 6.5 | 4.8 |
| Adjusted EBITDA margin | 4.0% | 9.0% | 0.6% | 10.8% | 2.9% | 12.4% | 15.9% | 15.5% |
| Stock-based compensation | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | | 0.1 | 0.1 |
| EBITDA [+] | 1.4 | 3.3 | 0.1 | 5.1 | 1.2 | | 6.4 | 4.7 |
| EBITDA growth | -56.2% | 4028.7% | -98.4% | 308.4% | 17580.7% | -99.9% | 37.0% | 113.1% |
| EBITDA margin | 3.7% | 8.6% | 0.2% | 10.8% | 2.7% | 12.4% | 15.7% | 15.2% |
| Depreciation and amortization | 2.8 | 2.6 | 2.9 | 3.4 | 3.2 | | 2.1 | 1.9 |
| EBIT [+] | -1.3 | 0.7 | -2.8 | 1.6 | -1.9 | 0.0 | 4.4 | 2.8 |
| EBIT growth | -278.8% | -126.7% | -272.7% | -183.9% | -27506.5% | -99.8% | 55.8% | 607.8% |
| EBIT margin | -3.4% | 1.9% | -7.5% | 3.4% | -4.2% | 12.4% | 10.6% | 9.0% |
| Non-recurring items [+] | 0.0 | 0.0 | 3.0 | 2.1 | 0.0 | | 0.0 | |
| Asset impairment | | | 3.0 | | | | | |
| Loss (gain) on sale of assets | 0.0 | 0.0 | | 2.1 | 0.0 | | 0.0 | |
| Interest expense | 0.1 | 0.2 | 0.2 | 0.4 | 0.4 | 0.0 | 0.5 | 0.4 |
| Interest expense | 0.1 | 0.2 | 0.2 | 0.4 | 0.4 | 0.0 | 0.5 | 0.4 |
| Other income (expense), net [+] | 0.0 | 0.0 | -0.1 | 0.1 | -0.1 | 0.0 | 0.0 | -0.1 |
| Gain (loss) on foreign currency transactions | 0.0 | -0.1 | -0.1 | 0.1 | -0.1 | | 0.0 | -0.1 |
| Other non-ooperating expenses | | | | | | | 0.0 | |
| Other | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Pre-tax income | -1.5 | 0.6 | -6.1 | -0.7 | -2.4 | 0.0 | 3.9 | 2.3 |
| Income taxes | -0.3 | 0.1 | 0.3 | -0.2 | -0.8 | 0.0 | 0.0 | 0.0 |
| Tax rate | 21.7% | 19.4% | | 25.2% | 33.8% | 16.9% | 1.2% | 0.7% |
| Net income | -1.1 | 0.4 | -6.4 | -0.6 | -1.6 | 0.0 | 3.9 | 2.3 |
| Net margin | -2.9% | 1.2% | -17.2% | -1.2% | -3.5% | 8.9% | 9.6% | 7.5% |
| |
| Basic EPS [+] | ($0.32) | $0.13 | ($2.11) | ($0.18) | ($0.54) | $1.81 | $1.89 | $1.22 |
| Growth | -343.9% | -106.2% | 1048.7% | -65.9% | -129.8% | -4.2% | 55.0% | -1274.6% |
| Diluted EPS [+] | ($0.32) | $0.13 | ($2.11) | ($0.18) | ($0.54) | $1.48 | $1.21 | $0.83 |
| Growth | -349.5% | -106.1% | 1048.7% | -65.9% | -136.3% | 22.2% | 45.7% | -903.0% |
| |
| Shares outstanding (basic) [+] | 3.5 | 3.4 | 3.0 | 3.0 | 3.0 | 0.0 | 2.1 | 1.9 |
| Growth | 4.9% | 12.0% | 0.0% | 0.4% | 107846.8% | -99.9% | 9.2% | 0.7% |
| Shares outstanding (diluted) [+] | 3.5 | 3.5 | 3.0 | 3.0 | 3.0 | 0.0 | 3.2 | 2.8 |
| Growth | 2.5% | 14.6% | 0.0% | 0.4% | 88350.2% | -99.9% | 16.2% | 47.3% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |